miR-1301-3p promotes invasion and migration and EMT progression in esophageal cancer by downregulating NBL1 expression.

Jianting DuShuliang ZhangXiaodan ZhangZhang YangSongtao XueGuobing XuBin Zheng Chun Chen

Published in: Thoracic cancer (2023)

MiR-1301-3p is a potential biomarker for predicting the prognosis of ESCA patients. It may promote ESCA invasion, migration and EMT progression by regulating NBL1 expression.

Keyphrases

poor prognosis
end stage renal disease
epithelial mesenchymal transition
cell migration
ejection fraction
newly diagnosed
chronic kidney disease
binding protein
peritoneal dialysis
patient reported outcomes
patient reported